Bacillus clausii for gastrointestinal disorders: A narrative literature review

View/ Open
Date
2022Author
Acosta Rodriguez Bueno, Carlos PatricioAbreu, Ana Teresa
Guarner, Francisco
Guno, Mary Jean
Pehlivanoğlu, Ender
Perez, Marcos
Metadata
Show full item recordCitation
Acosta-Rodríguez-Bueno, CP; Abreu, AT; Guarner, F; Guno, MJ; Pehlivanoglu, E; Perez, M. Bacillus clausii for gastrointestinal disorders: A narrative literature review. Advances in Therapy (2022). 39(11):4854–4874.Abstract
The gut microbiota is intrinsically linked to human health; disturbances in microbial homeostasis are implicated in both intestinal and extraintestinal disorders. Probiotics are "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host," and many commercial preparations comprising a diverse range of species are available. While probiotics have been much researched, better understanding of the probiotic effects and applications of species such as Bacillus clausii is warranted. In this narrative literature review, we review the characteristics and mechanisms of action supporting B. clausii as a probiotic and discuss the evidence from clinical studies evaluating B. clausii probiotics for the management of a variety of gastrointestinal disorders and symptoms in children and adults. Finally, we highlight the challenges of future research and the need for more robust and diverse clinical evidence to guide physicians in the clinical application of probiotics for gastrointestinal disorders and other conditions.
Source
Advances in TherapyVolume
39Issue
11URI
https://link.springer.com/article/10.1007/s12325-022-02285-0https://doi.org/10.1007/s12325-022-02285-0
https://hdl.handle.net/20.500.12780/683